GlassScriptPhysician profile
Corazon Alvarado
NPI 1083775183
$2,029.92
in general payments reported to CMS, 2019-2025
17 companies · $22.25 in 2025
The $22.25 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $676 · 2022: $585 · 2023: $615 · 2024: $132 · 2025: $22.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $691 · Education: $77.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $691.16 |
| Education | $77.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Opko Pharmaceuticals, LLC | $785.36 | 2021-2024 | Rayaldee |
| Merck Sharp & Dohme LLC | $253.05 | 2021-2024 | Verquvo, Belsomra |
| Novo Nordisk INC | $239.30 | 2021-2023 | Ozempic, Rybelsus |
| Lilly USA, LLC | $178.17 | 2021-2023 | Mounjaro |
| Amgen INC. | $104.45 | 2021-2023 | Otezla, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $102.29 | 2022-2024 | |
| Otsuka America Pharmaceutical, INC. | $85.12 | 2024-2025 | Jynarque, Rexulti |
| Astrazeneca Pharmaceuticals LP | $60.68 | 2021-2023 | Lokelma |
| Sanofi-Aventis U.S. LLC | $41.45 | 2021-2022 | |
| Calliditas Therapeutics US INC. | $32.02 | 2022-2023 | Tarpeyo |
| Idorsia Pharmaceuticals US INC | $31.41 | 2023 | Quviviq |
| Novartis Pharmaceuticals Corporation | $27.10 | 2022 | |
| Abbott Laboratories | $23.26 | 2023 | Freestyle Libre 2 |
| Dexcom, INC. | $17.35 | 2021 | |
| Genzyme Corporation | $17.35 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $16.61 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corazon Alvarado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.